Related Experiment Videos
Evidence-based management of polycythemia vera
Tiziano Barbui1, Guido Finazzi
1Department of Hematology, Ospedali Riuniti di Bergamo, Largo Barozzi 1, 24128 Bergamo, Italy. tbarbui@ospedaliriuniti.bergamo.it
Best Practice & Research. Clinical Haematology
|June 20, 2006
Summary
Polycythemia vera management aims to reduce blood clots and prevent disease progression. Evidence-based approaches are crucial for optimizing patient outcomes and survival.
Area of Science:
- Hematology
- Oncology
Background:
- Polycythemia vera presents significant risks of thrombosis and transformation to myelofibrosis or acute myeloid leukemia.
- Current treatments like phlebotomy, chemotherapy, and aspirin reduce thrombotic events and improve survival.
- Concerns exist regarding myelosuppressive drugs potentially accelerating leukemic transformation.
Purpose of the Study:
- To provide updated risk assessments for thrombosis and disease progression in polycythemia vera.
- To evaluate existing randomized and observational studies on polycythemia vera management.
- To guide evidence-based clinical strategies for polycythemia vera.
Main Methods:
- Review of randomized controlled trials and observational studies in polycythemia vera.
- Evidence-based analysis of treatment efficacy and risks.
- Updated estimation of thrombosis and disease progression risks.
Main Results:
- Cytoreductive therapies and aspirin have significantly decreased thrombotic complications and improved survival.
- Certain myelosuppressive agents may increase the risk of acute leukemia transformation.
- Risk stratification for thrombosis and progression is essential for personalized management.
Conclusions:
- Effective management of polycythemia vera requires balancing the reduction of thrombotic events with the prevention of myelofibrotic or leukemic transformation.
- An evidence-based approach is vital for optimizing therapeutic strategies.
- Continued research is needed to refine treatment protocols and minimize long-term disease risks.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...